1,404
Views
4
CrossRef citations to date
0
Altmetric
Research Article

SARS-CoV-2 antibody seroprevalence after the first wave among workers at a community healthcare system in the Greater Boston area

, , , , , , , & show all

References

  • Lan F-Y, Fernandez-Montero A, Kales SN. COVID-19 and healthcare workers: emerging patterns in Pamplona, Asia and Boston. Occup Med (Lond). 2020;70:340–341.
  • Lan FY, Wei CF, Hsu YT, et al. Work-related COVID-19 transmission in six Asian countries/areas: a follow-up study. PLoS One. 2020;15:e0233588.
  • Lai CC, Wang JH, Hsueh PR. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review. Int J Infect Dis. 2020;S1201-9712(20):32214.
  • Federal Reserve Bank of Cleveland. COVID-19 mortality rate trends in countries and US states. cited 2020 Nov 9. Available from: https://www.clevelandfed.org/newsroom-and-events/publications/cfed-district-data-briefs/cfddb-20200513-covid19-mortality-rate-trends-series.aspx
  • Roy V, Fischinger S, Atyeo C, et al. SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020;484–485:112832.
  • Lan FY, Filler R, Mathew S, et al. COVID-19 symptoms predictive of healthcare workers’ SARS-CoV-2 PCR results. PLoS One. 2020;15:e0235460.
  • Self WH, Tenforde MW, Stubblefield WB, et al. Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 academic medical centers, April-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1221–1226.
  • Korth J, Wilde B, Dolff S, et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol. 2020;128:104437.
  • Hunter BR, Dbeibo L, Weaver CS, et al. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure. Infect Control Hosp Epidemiol. 2020;41:1441–1442.
  • Moscola J, Sembajwe G, Jarrett M, et al. Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City area. JAMA. 2020;324:893–895.
  • Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection, a narrative review. Ann Intern Med. 2020;173:362–367.
  • Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370:eabd7728.
  • Iyer AS, Jones FK, Nodoushani A, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020;5:eabe0367.
  • Lan FY, Filler R, Soni M, et al. Sociodemographic risk factors for COVID-19 infection among Massachusetts healthcare workers: a retrospective cohort study. Infect Control Hosp Epidemiol. 2021;DOI:https://doi.org/10.1017/ice.2021.17.